Medical News

RSS

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

Today, Secretary of Health and Human Services Kathleen Sebelius announced her intent to appoint Helene Gayle, MD, MPH to serve as the Chair of the Presidential Advisory Council on HIV/AIDS. Secretary Sebelius made the announcement in Atlanta at the 2009 National HIV Prevention Conference.

25 Aug 2009

Boston Scientific Corporation to webcast conference call to discuss results of Landmark MADIT-CRT trial

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing final results from the landmark MADIT-CRT trial on Tuesday, September 1, at 8:00 a.m. ET / 2:00 p.m. Barcelona time.

25 Aug 2009

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

In order to reduce the Province's greenhouse gas emissions, the BC Bioenergy Strategy is calling for greatly increased production of renewable biofuels such as ethanol, from biomass grown in BC. Two new research projects, largely funded by Genome BC, will help to answer these questions and unlock the valuable green energy found within BC's forests.

25 Aug 2009

NCI investigator’s endorsement of of inaccurate high-risk HPV test to refer women to cervical cancer tests is “unfortunate and inappropriate” says Sin Hang Lee

A National Cancer Institute (NCI) investigator’s endorsement of inaccurate high-risk HPV test to refer women to cervical cancer tests, despite the weak evidence of its value, is “unfortunate and inappropriate.”

25 Aug 2009

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that study results demonstrated that arimoclomol exhibited both statistically significant neuroprotective and neuroregenerative effects in brain cells of animals induced with stroke, offering important insights into this drug candidate’s mechanism of action.

25 Aug 2009

New office opened in Houston by Hospice Compassus

Hospice Compassus, a leading provider of hospice services, announced today the opening of its fourth Houston-area location.

25 Aug 2009

NanoBusiness 2009 conference to address nanotechnology advancements in various markets

The NanoBusiness Alliance, the world's leading nanotechnology trade association, today announced details of its expanded conference program for the 8th annual NanoBusiness 2009 conference and exhibition, which will held at McCormick Place in Chicago, IL, from September 8 – 10.

25 Aug 2009

IDenta releases updates on new sales activities

IDenta Corp. (PINKSHEETS: IDTA) today released updates of some of the recent sales activity of IDenta products.

25 Aug 2009

Bioneutral Group holds scientific and business discussions with major health care companies

BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced discussions with four of the world’s largest health care companies.

25 Aug 2009

CenterWatch senior edtior to deliver keynote address at KIKA’s U.S. User Group Meeting

KIKA Clinical Solutions announced that Sara Gambrill, Senior Editor of CenterWatch, will be a keynote speaker at KIKA’s U.S. User Group Meeting. KIKA is the leading provider of advanced EDC solutions for clinical trials, and creators of the Veracity Web-based platform for Clinical Asset Management. The User Group Meeting will take place October 21 and 22 in Boston.

25 Aug 2009

Awareness campaign on sun protection by Portland dermatologists at the LPGA Safeway Classic

In a region known more for its rainfall than sunshine, a team of Portland dermatologists representing the Women's Dermatologic Society (WDS) will return for the third time in six years to the LPGA Safeway Classic to promote sun safety for all seasons and skin types. This picturesque yet often cloudy venue has proven to draw golf lovers who need greater awareness about skin protection, as shown by the previous screenings' 37% skin cancer discovery rate.

25 Aug 2009

Dalai Lama to participate in The Mind and Life Institute's Washington D.C. conference

On Oct. 8-9, 2009, the Dalai Lama will participate in our Washington D.C. conference, Educating World Citizens for the 21st Century. The goal of this ML XIX conference is to explore the value of integrating emotional, intellectual and social learning into today's educational programs with the intention to promote education research into these areas.

25 Aug 2009

Navinet offers its real-time healthcare communications solution to all state governments and U.S. territories at no cost

NaviNet (formerly NaviMedix), America’s largest real-time healthcare communications network, today announced the NaviNet Health Information Exchange (HIE), a solution that combines the NaviNet Provider Network of more than 770,000 providers nationwide, and NaviNet technology and services.

25 Aug 2009

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

Tripep and the German biotech company Cosmix AG have both licensed their respective technologies (RAS and mRNA Display Library) to a newly formed US company named Opsonic Therapeuticals Inc. within which Tripep’s RAS technology will be developed.

25 Aug 2009

First patient enrolled for IDEV Technologies' SUPERB clinical trial

IDEV(R) Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that the first patient was enrolled in the Company's FDA-approved multi-center clinical trial of its self-expanding SUPERA(R) stent, a novel stent platform designed for the treatment of biliary and peripheral artery disease (PAD) in the superficial femoral artery (SFA).

25 Aug 2009

Subject enrollment in patients with retinitis pigmentosa for Phase 2 clinical study completed by R-Tech Ueno

We are pleased to announce that subject enrollment for the phase 2 clinical study of 0.15% UF-021 (generic name; isopropyl unoprostone; active ingredient of Rescula(R) eye-drops) in patients with retinitis pigmentosa has been completed.

25 Aug 2009

Illumina's new stock repurchase program effective in returning value to shareholders

Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the Company to repurchase in the aggregate up to $75 million of its outstanding common stock.

From Illumina, Inc. 25 Aug 2009

Cybex International re-brands its research division as Cybex Institute For Exercise Science

Cybex International, Inc., a leading manufacturer of premium exercise equipment for the commercial and consumer markets, announced today the re-branding of its research arm as the Cybex Institute for Exercise Science, with the continued mission of disseminating scientifically accurate information applicable to the disciplines of general fitness, sports performance and clinical medicine.

25 Aug 2009

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

Bavarian Nordic A/S (OMX: BAVA) announced today that the US authorities have initiated negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE(R) smallpox vaccine.

25 Aug 2009

Seattle Genetics completes enrollment of its pivotal clinical trial of brentuximab vedotin

Seattle Genetics, Inc. today announced that it has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30 utilizing the company’s proprietary ADC technology.

25 Aug 2009

Medical News

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

Boston Scientific Corporation to webcast conference call to discuss results of Landmark MADIT-CRT trial

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

NCI investigator’s endorsement of of inaccurate high-risk HPV test to refer women to cervical cancer tests is “unfortunate and inappropriate” says Sin Hang Lee

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

New office opened in Houston by Hospice Compassus

NanoBusiness 2009 conference to address nanotechnology advancements in various markets

IDenta releases updates on new sales activities

Bioneutral Group holds scientific and business discussions with major health care companies

CenterWatch senior edtior to deliver keynote address at KIKA’s U.S. User Group Meeting

Awareness campaign on sun protection by Portland dermatologists at the LPGA Safeway Classic

Dalai Lama to participate in The Mind and Life Institute's Washington D.C. conference

Navinet offers its real-time healthcare communications solution to all state governments and U.S. territories at no cost

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

First patient enrolled for IDEV Technologies' SUPERB clinical trial

Subject enrollment in patients with retinitis pigmentosa for Phase 2 clinical study completed by R-Tech Ueno

Illumina's new stock repurchase program effective in returning value to shareholders

Cybex International re-brands its research division as Cybex Institute For Exercise Science

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

Seattle Genetics completes enrollment of its pivotal clinical trial of brentuximab vedotin

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News